Lawyer

Thomas Champagne

• Called to the Barreau du Québec (2021)
• Graduate diploma in common law and transnational law (J.D.), Université de Sherbrooke (2020)
• Bachelor of Laws, Université de Sherbrooke (2020)

• Acted on behalf of Genesis Drug Discovery & Development, member of Genesis Global Group, in its acquisition of JSS Medical Research, an enterprise with corporate headquarters in Montréal, Canada, and regional offices in Bogotá, Columbia, Faridabad, India, and Warsaw, Poland, which provides pre- and post-approval clinical development services to support pharmaceutical, biotechnology, nutraceutical and medical device companies worldwide. (2023);
• Acted on behalf of the shareholders of Les Espaces Memoria Inc. and its subsidiaries, a leading funeral services company in the greater metropolitan area, regarding the sale of their shares to Athos Commemorative Services Inc. the largest private network of funeral complexes in Québec (2023);
• Acted on behalf of RPM International inc. (NYSE: RPM), a U.S.-based multinational corporation, in the course of its acquisition of Entreprises Prostamp Inc., a corporation specializing in the manufacture of various construction parts using stamping, machining and welding processes (September 2022);
• Acted on behalf of an American investment fund in the acquisition in Québec of a private security company operating in Canada and the United States (September 2022);
• Acted on behalf of Notarius, a Quebec-based and Canadian leader and provider of solutions that safeguard the long-term reliability of electronic documents, in its acquisition by Portage CyberTech Inc., a subsidiary of Converge Technology Solutions Corp., a software-enabled IT & Cloud Solutions provider. (June 2022);
• Acted on behalf of GFL Environment and Matrec in multiple acquisitions of companies of waste sorting and recycling in the province of Quebec (May and June 2022);
• Acted as lead counsel for Clareo Inc., Québec's largest network of dental clinics, in the context of its strategic partnership with the International Dental Institute (IDI) (April 2022);
• Acted on behalf of Sika, a global manufacturer of specialty construction products, in its acquisition of Sable Marco Inc. (March 2022);
• Acted on behalf of the acquiring group in the going private transaction of Sportscene Group Inc. owning, among others, La Cage-Brasserie Sportive restaurants (January 2022);
• Acted on behalf of Baylis Medical Company Inc. and its shareholders in the US$1.75 billion sale of the company's cardiology division to Boston Scientific Corporation (NYSE: BSX) and the divestiture of its DMS division (October 2021);
• Acted on behalf of DMD Connects Services Inc. in the sale of its direct and indirect interests and assets used in the operation of DMD Marketing Corp, a healthcare information provider designed to connect marketers with leading healthcare professionals, to IQVIA Inc. (NYSE: IQVIA) (August 2021);
• Acted on behalf of Groupe Nexio Inc. in connection with its acquisition by Novacap (August 2021).